Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Jerrod Felder

Sports Medicine Lexington, KY Medical Doctor

NPI 1578797395 CMS profile 379667

740 S. Limestone Street, K401 Kentucky Clinic, Lexington, KY 40536

Open in the dashboard

General payments

$6,059

54 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Jerrod Felder of Lexington, KY is reported in the CMS Open Payments database as having received $6,059 across 54 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 46th percentile of Sports Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $385 5
2024 General $1,808 7
2023 General $591 5
2022 General $2,513 15
2021 General $212 9
2020 General $187 6
2019 General $364 7

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Jerrod Felder
  • Sports Medicine median
  • Middle half of Sports Medicine
  • National median

In program year 2025, general payments to Jerrod Felder were reported at $385. Among 2,404 Sports Medicine profiles paid that year, the median was $664 and the middle half received between $172 and $3,055.

Show as a table
Year Jerrod Felder Sports Medicine median Middle half National median
2019 $364 $1,176 $199–$4,249 $163
2020 $187 $708 $96–$2,890 $114
2021 $212 $1,213 $152–$3,994 $132
2022 $2,513 $1,230 $159–$3,998 $149
2023 $591 $584 $146–$2,836 $160
2024 $1,808 $628 $163–$3,168 $164
2025 $385 $664 $172–$3,055 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Smith+Nephew, Inc. $2,843 19 payments
  2. Shoulder Innovations, Inc. $1,676 6 payments
  3. DePuy Synthes Sales Inc. $647 19 payments
  4. Miach Orthopaedics, Inc. $243 1 payment
  5. Medical Device Business Services, Inc. $209 2 payments
  6. Stryker Corporation $169 1 payment
  7. Vericel Corporation $154 2 payments
  8. Piedmont Plus Innovation $37 1 payment
  9. Ethicon US, LLC $35 1 payment
  10. Biocomposites Inc $27 1 payment
  11. Other $18 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $3,162 48 payments
  2. Travel and Lodging $2,889 5 payments
  3. Education $8 1 payment
Products named General payments · program years 2019–2025
  1. Bioinductive Implant with Arthroscopic Delivery System - Medium $1,857 12 payments
  2. InSet System $1,676 6 payments
  3. ENDOBUTTON $1,478 9 payments
  4. Mini-Open Latarjet $1,469 8 payments
  5. HEALICOIL $528 1 payment
  6. Bone Anchors with Arthroscopic Delivery System $268 2 payments
  7. INSPACE $169 1 payment
  8. ATTUNE $116 1 payment
  9. MACI $111 1 payment
  10. EXPAREL $93 1 payment
  11. Other $947 28 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 14 drugs

Part D claims

1,366

Median for Orthopedic Surgery: 203

Drug cost

$14,006

Median for Orthopedic Surgery: $1,433

Branded share of claims

20.2%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Diclofenac Sodium Generic 200 $8,323
Celecoxib Generic 55 $1,203
Methylprednisolone Generic 171 $1,097
Meloxicam Generic 368 $914
Gabapentin Generic 31 $536
Cyclobenzaprine Hcl Generic 122 $525
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 43 $325
Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav Brand 207 $314
Pregabalin Generic 15 $204
Ondansetron Hcl Generic 38 $178

The 10 drugs with the highest cost, of 14 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 75 billing codes

Paid by Medicare

$103,256

Of which drugs: $6,384

Medicare patients

262

Average age 74

Services billed

3,489

154 women, 108 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 71%
Chronic kidney disease 31%
Diabetes 30%
Ischemic heart disease 22%
Depression 21%
Osteoporosis 19%
Atrial fibrillation 16%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, triamcinolone acetonide, not otherwise specified, 10 mg J3301 Office 102 1,412 $1,012
Injection, ropivacaine hydrochloride, 1 mg J2795 Office 24 500 $26

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

54 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Sports Medicine in Kentucky

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record